Radiopharmaceuticals
Ended Purchase Order Awarded Last action
- Contract number
- 36C24425P0153
- Awardee
-
Jubilant Draximage Radiopharmacies, Inc. UEI ZL79MXYVNDM1
- Awarding agency
-
Veterans Integrated Service Network 4
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $235,844
Award facts
- Opportunity
-
- Radiopharm-Tc-99m-Wilmington VAMC Solicitation · 36C24425Q0142 · Posted Nov 26, 2024
- Contract value 30% obligated
-
- $235,844.19 Current, with exercised options
- $799,127.29 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Wilmington, DE 19805, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$124,479 | |
| Exercise an Option | $180,169 | |
| Other Administrative Action | $0 | |
| Original award | $180,154 |
About this award
Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, was awarded a $799,127.29 firm fixed-price purchase order by the Department of Veterans Affairs Veterans Integrated Service Network 4 on January 1, 2025, to supply radiopharmaceuticals to the Wilmington VA Medical Center in Wilmington, Delaware through December 31, 2025. The award was not issued under a small business set-aside. As a for-profit small disadvantaged business specializing in the manufacturing and distribution of nuclear medicine products, Jubilant Radiopharma was selected to meet the VA's stringent requirements for rapid delivery of radiopharmaceuticals, including products such as Sestamibi Tc-99m, Sodium Pertechnetate Tc-99m, and Medronate Tc-99m. The contractor must maintain Nuclear Regulatory Commission and Delaware State licensing, provide expert consultation services, and deliver products within two hours of order placement with daily deliveries by 7:00 AM.
This award supports the VA's nuclear medicine diagnostic and therapeutic imaging operations across its healthcare network. Jubilant Radiopharma serves as a key supplier to the VA, holding multiple indefinite delivery vehicles and blanket purchase agreements with various Veterans Integrated Service Networks, with total contract values ranging from approximately $220,000 to $39.8 million and extending through 2030. The company operates as the prime contractor on all awards with no identified subcontractors, leveraging its specialized capabilities in radiopharmaceutical manufacturing and distribution to ensure veterans have consistent access to advanced diagnostic imaging and therapeutic nuclear medicine products across the VA system.
Quick answers
Who was awarded contract 36C24425P0153?
36C24425P0153 was awarded to Jubilant Draximage Radiopharmacies, Inc. by Veterans Integrated Service Network 4 (Veterans Health Administration) on January 1, 2025.
How much is contract 36C24425P0153 worth?
The government has obligated $235,844 on 36C24425P0153. Its potential value, with all options, is $799,127.
Was contract 36C24425P0153 competed?
The extent of competition for 36C24425P0153 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award